chr7-152247986-G-GT

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 8P and 2B. PVS1BP6_Moderate

The NM_170606.3(KMT2C):​c.2447dupA​(p.Tyr816fs) variant causes a frameshift, stop gained change. Variant has been reported in ClinVar as Benign (★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.49 ( 0 hom., cov: 0)
Exomes 𝑓: 0.49 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

KMT2C
NM_170606.3 frameshift, stop_gained

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 4.77

Publications

24 publications found
Variant links:
Genes affected
KMT2C (HGNC:13726): (lysine methyltransferase 2C) This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]
KMT2C Gene-Disease associations (from GenCC):
  • Kleefstra syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics, Broad Center for Mendelian Genomics
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BP6
Variant 7-152247986-G-GT is Benign according to our data. Variant chr7-152247986-G-GT is described in ClinVar as Benign. ClinVar VariationId is 403020.Status of the report is criteria_provided_single_submitter, 1 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_170606.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KMT2C
NM_170606.3
MANE Select
c.2447dupAp.Tyr816fs
frameshift stop_gained
Exon 14 of 59NP_733751.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KMT2C
ENST00000262189.11
TSL:1 MANE Select
c.2447dupAp.Tyr816fs
frameshift stop_gained
Exon 14 of 59ENSP00000262189.6
KMT2C
ENST00000682283.1
c.2447dupAp.Tyr816fs
frameshift stop_gained
Exon 14 of 60ENSP00000507485.1
KMT2C
ENST00000679882.1
c.2447dupAp.Tyr816fs
frameshift stop_gained
Exon 14 of 56ENSP00000506154.1

Frequencies

GnomAD3 genomes
AF:
0.495
AC:
72119
AN:
145804
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.497
Gnomad AMI
AF:
0.499
Gnomad AMR
AF:
0.494
Gnomad ASJ
AF:
0.493
Gnomad EAS
AF:
0.500
Gnomad SAS
AF:
0.498
Gnomad FIN
AF:
0.493
Gnomad MID
AF:
0.490
Gnomad NFE
AF:
0.493
Gnomad OTH
AF:
0.492
GnomAD2 exomes
AF:
0.487
AC:
81747
AN:
167790
AF XY:
0.488
show subpopulations
Gnomad AFR exome
AF:
0.471
Gnomad AMR exome
AF:
0.489
Gnomad ASJ exome
AF:
0.483
Gnomad EAS exome
AF:
0.498
Gnomad FIN exome
AF:
0.490
Gnomad NFE exome
AF:
0.485
Gnomad OTH exome
AF:
0.478
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR;InbreedingCoeff
AF:
0.492
AC:
635498
AN:
1292742
Hom.:
0
Cov.:
75
AF XY:
0.492
AC XY:
317601
AN XY:
645684
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.496
AC:
14894
AN:
30056
American (AMR)
AF:
0.495
AC:
20393
AN:
41178
Ashkenazi Jewish (ASJ)
AF:
0.489
AC:
11352
AN:
23226
East Asian (EAS)
AF:
0.500
AC:
19512
AN:
39040
South Asian (SAS)
AF:
0.498
AC:
41128
AN:
82504
European-Finnish (FIN)
AF:
0.492
AC:
24311
AN:
49462
Middle Eastern (MID)
AF:
0.491
AC:
2580
AN:
5256
European-Non Finnish (NFE)
AF:
0.490
AC:
474876
AN:
968238
Other (OTH)
AF:
0.492
AC:
26452
AN:
53782
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.324
Heterozygous variant carriers
0
38851
77702
116552
155403
194254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
18386
36772
55158
73544
91930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.495
AC:
72179
AN:
145924
Hom.:
0
Cov.:
0
AF XY:
0.495
AC XY:
35339
AN XY:
71454
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.497
AC:
19865
AN:
40008
American (AMR)
AF:
0.494
AC:
7276
AN:
14714
Ashkenazi Jewish (ASJ)
AF:
0.493
AC:
1637
AN:
3318
East Asian (EAS)
AF:
0.500
AC:
2534
AN:
5068
South Asian (SAS)
AF:
0.498
AC:
2337
AN:
4694
European-Finnish (FIN)
AF:
0.493
AC:
4991
AN:
10120
Middle Eastern (MID)
AF:
0.489
AC:
134
AN:
274
European-Non Finnish (NFE)
AF:
0.493
AC:
31978
AN:
64842
Other (OTH)
AF:
0.493
AC:
988
AN:
2006
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.384
Heterozygous variant carriers
0
3433
6867
10300
13734
17167
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
872
1744
2616
3488
4360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.488
Hom.:
0

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Apr 25, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: frequency

Intellectual disability Benign:1
Jan 01, 2019
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.8
Mutation Taster
=0/200
disease causing (fs/PTC)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150073007; hg19: chr7-151945071; COSMIC: COSV51275813; API